8.7%
Revenue Growth
MDT achieved an 8.7% increase in revenue, driven by strong sales across key segments.
来源: Source: 10-Q Income Statement, p.1
中文版正在生成中，先为你展示英文版分析。
AI核心结论
In Q3 FY2026, MDT reported a revenue increase of 8.7% but faced declining operating and net income due to rising costs, impacting margins and earnings per share.
营业收入
$9.02B
同比 ++8.74%
每股收益（基本）
$0.89
同比 -11.88%
营业利润
$1.46B
同比 -11.06%
提交于 · 解读更新于 · 来源: SEC EDGAR 10-Q 原文
Medtronic (MDT) Q3 FY2026 营收 $9.02B，同比增长 8.7%。 净利润 $1.14B，同比下降 11.7%，稀释每股收益 $0.89。
MDT achieved an 8.7% increase in revenue, driven by strong sales across key segments.
来源: Source: 10-Q Income Statement, p.1
The cost of revenue increased by 17.3%, significantly impacting operating income and margins.
来源: Source: 10-Q Income Statement, p.1
Operating margin decreased to 16.2% from 19.9%, reflecting higher SG&A expenses and cost of revenue.
来源: Source: 10-Q Key Ratios, p.1
The company experienced a 17.3% increase in the cost of revenue, which could continue to pressure margins if inflation persists.
来源: Source: 10-Q Income Statement, p.1
Share buybacks decreased by 79.7% year-over-year, potentially impacting shareholder returns.
来源: Source: 10-Q Cash Flow, p.1
With a debt to equity ratio of 0.86, MDT's leverage could pose risks if interest rates rise.
来源: Source: 10-Q Key Ratios, p.1
Q3 FY2026 实际 EPS $1.36，分析师一致预期 $1.35，超预期 +0.9%。
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
营业收入 | $9.02B | $8.29B | +8.74% |
营业成本 | $3.26B | $2.78B | +17.34% |
营业利润 | $1.46B | $1.65B | -11.06% |
净利润 | $1.14B | $1.29B | -11.67% |
每股收益（基本） | $0.89 | $1.01 | -11.88% |
每股收益（稀释） | $0.89 | $1.01 | -11.88% |
销售及管理费用 | $2.96B | $2.72B | +8.80% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
总资产 | $91.48B | $89.97B | +1.68% |
流动资产 | $24.07B | $22.51B | +6.92% |
总负债 | $42.29B | $40.36B | +4.78% |
流动负债 | $9.49B | $11.84B | -19.81% |
股东权益 | $48.98B | $49.39B | -0.81% |
现金及等价物 | $1.15B | $1.24B | -7.50% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
经营活动现金流YTD | $4.76B | $4.52B | +5.34% |
投资活动现金流YTD | $-2.02B | $-1.45B | -39.39% |
筹资活动现金流YTD | $-3.86B | $-3.02B | -28.00% |
股票回购YTD | $600M | $2.96B | -79.74% |
折旧及摊销YTD | $2.24B | $2.02B | +10.94% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
营业利润率 | 16.2% | 19.9% | -3.61% |
净利率 | 12.7% | — | — |
净资产收益率 | 2.3% | — | — |
总资产收益率 | 1.2% | — | — |
流动比率 | $2.535 | — | — |
资产负债率 | $0.863 | — | — |
Health Care Equipment 行业其他公司
MDT's EPS for Q3 FY2026 was $0.89, a decrease of 11.9% from the previous year, but the filing does not provide specific estimates for comparison.
Key takeaways include an 8.7% revenue increase, a decline in operating income by 11.1%, and a reduction in EPS to $0.89 due to rising costs.
MDT highlighted risks such as cost inflation impacting margins, decreased share buybacks, and high debt levels.
MDT's revenue grew by 8.7% to $9.02B, driven by strong sales across its segments.
MDT maintains a strong current ratio of 2.54, but faces challenges with declining margins and high debt levels.